As of 2025-12-19, the Relative Valuation of Evolent Health Inc (EVH) is (36.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.97 USD, the upside of Evolent Health Inc based on Relative Valuation is -1009.9%.
The range of the Relative Valuation is (35.08) - (38.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 30.5x - 33.8x | 32.4x |
| Forward P/E multiples | 30.0x - 34.5x | 30.5x |
| Fair Price | (35.08) - (38.87) | (36.12) |
| Upside | -983.6% - -1079.0% | -1009.9% |
| Date | P/E |
| 2025-12-18 | -3.46 |
| 2025-12-17 | -3.52 |
| 2025-12-16 | -3.54 |
| 2025-12-15 | -3.59 |
| 2025-12-12 | -3.59 |
| 2025-12-11 | -3.43 |
| 2025-12-10 | -3.38 |
| 2025-12-09 | -3.43 |
| 2025-12-08 | -3.42 |
| 2025-12-05 | -3.43 |
| 2025-12-04 | -3.49 |
| 2025-12-03 | -3.40 |
| 2025-12-02 | -3.38 |
| 2025-12-01 | -3.48 |
| 2025-11-28 | -3.66 |
| 2025-11-26 | -3.66 |
| 2025-11-25 | -3.75 |
| 2025-11-24 | -3.72 |
| 2025-11-21 | -3.60 |
| 2025-11-20 | -3.21 |
| 2025-11-19 | -3.08 |
| 2025-11-18 | -3.48 |
| 2025-11-17 | -3.37 |
| 2025-11-14 | -3.64 |
| 2025-11-13 | -3.62 |
| 2025-11-12 | -3.87 |
| 2025-11-11 | -4.39 |
| 2025-11-10 | -4.31 |
| 2025-11-07 | -4.32 |
| 2025-11-06 | -5.22 |
| 2025-11-05 | -5.53 |
| 2025-11-04 | -5.65 |
| 2025-11-03 | -5.85 |
| 2025-10-31 | -5.81 |
| 2025-10-30 | -5.75 |
| 2025-10-29 | -6.16 |
| 2025-10-28 | -6.45 |
| 2025-10-27 | -6.65 |
| 2025-10-24 | -6.80 |
| 2025-10-23 | -6.53 |
| 2025-10-22 | -7.03 |
| 2025-10-21 | -7.12 |
| 2025-10-20 | -6.76 |
| 2025-10-17 | -6.56 |
| 2025-10-16 | -6.79 |
| 2025-10-15 | -6.83 |
| 2025-10-14 | -6.71 |
| 2025-10-13 | -6.69 |
| 2025-10-10 | -6.91 |
| 2025-10-09 | -7.11 |